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1. Introduction
The physical advantage of carbon ion therapy lies in its high ballistic precision in longitudinal and transversal 
direction, but it also makes it more sensitive to deviations from the treatment plan. Since carbon ions undergo 
nuclear reactions in tissue and create positron emitters like 11C (T1/2  =  20.39 min) and 15O (T1/2  =  2.03 min) 
(Tomitami et al 1993, Parodi et al 2002), positron emission tomography (PET) has been introduced as an in 
vivo treatment verification tool (Enghardt et al 1999, Shakirin et al 2011, Bauer et al 2013a). Due to different 
underlying physical processes, dose deposition and positron emitter activation are not directly comparable to 
each other, which prevents direct treatment verification. However, with the support of simulation platforms, 
a prediction of the positron emission profile can be obtained and its comparison to the measurement allows 
for treatment verification, when physical decay and biological washout are taken into consideration (Bauer 
et al 2013b). If the two distributions agree within a small range of uncertainty, the treatment is assumed to have 
been delivered correctly. In contrast, differences between the two distributions indicate deviations between the 
delivered and planned treatment and the consequential need for a revision and refinement of the treatment plan 
or patient setup.
Since dose is primarily delivered in electromagnetic processes and positron emitters are created in nuclear 
reactions, a reliable prediction of the PET image currently requires complex and time-consuming Monte Carlo 
(MC) simulations that consider the initial ion beam properties and all electromagnetic and nuclear reactions in 
tissue. To overcome this drawback and make range verification with PET imaging more convenient for clinical 
practice, Parodi and Bortfeld showed for proton therapy that there must exist a function whose convolution with 
the depth dose distribution yields the positron emitter distribution (PED) (Parodi and Bortfeld 2006). With an 
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Abstract
Range verification is one of the most relevant tasks in ion beam therapy. In the case of carbon ion 
therapy, positron emission tomography (PET) is the most widely used method for this purpose, 
which images the β+-activation following nuclear interactions of the ions with the tissue nuclei. Since 
the positron emitter activity profile is not directly proportional to the dose distribution, until today 
only its comparison to a prediction of the PET profile allows for treatment verification. Usually, this 
prediction is obtained from time-consuming Monte Carlo simulations of high computational effort, 
which impacts the clinical workflow. To solve this issue in proton therapy, a convolution approach was 
suggested to predict positron emitter activity profiles from depth dose distributions analytically. In 
this work, we introduce an approach to predict positron emitter distributions from depth dose profiles 
in carbon ion therapy. While the distal fall-off position of the positron emitter profile is predicted from 
a convolution approach similar to the one suggested for protons, additional analytical functions are 
introduced to describe the characteristics of the positron emitter distribution in tissue. The feasibility 
of this approach is demonstrated with monoenergetic depth dose profiles and spread out Bragg peaks 
in homogeneous and heterogeneous phantoms. In all cases, the positron emitter profile is predicted 
with high precision and the distal fall-off position is reproduced with millimeter accuracy.
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appropriate filter kernel obtained from fitting procedures, the one-dimensional positron emitter activity distri-
bution can be predicted via convolution from a depth dose distribution with millimetre accuracy in very short 
time. The feasibility of this procedure for clinical implementation has been shown successfully in three dimen-
sions for offline and in-room PET imaging in proton therapy (Parodi et al 2007a, Attanasi et al 2011, Frey et al 
2014).
Another approach for analytical prediction of PET monitoring distributions was suggested by Priegnitz et al 
(2012). Therein, the authors acquired experimental positron emitter yields in different phantoms of simple com-
position (graphite, polyethylene (PE), water and polymethyl methacrylate (PMMA)) to then create an analytical 
model to predict PET distributions.
In contrast to protons, carbon ions undergo projectile fragmentation which leads to different properties of 
the positron emitter activity profile. In particular, while positron emitters in proton therapy are created solely 
from target nuclei, the projectiles in carbon ion therapy fragment into positron emitters themselves as well, giv-
ing rise to a characteristic positron emitter profile maximum close to the Bragg peak of the dose distribution 
(Enghardt et al 1992).
In this work, we extend and modify the filtering approach to make it suitable for carbon ion therapy and 
predict the positron emitter distribution from the depth dose distribution analytically. The method is applied to 
depth dose distributions and its results are compared to positron emitter distributions which are created by MC 
simulations described in section 2.1. The convolution approach in proton therapy and our analytical approach to 
predict positron emitter distributions from dose profiles in carbon ion therapy in one dimension are presented 
in section 2.2. In section 3, the results of the application of this method to data from monoenergetic carbon ion 
beams of therapeutic energies and spread-out Bragg peaks (SOBPs) impinging on homogeneous and heteroge-
neous phantoms are demonstrated.
Finally, a discussion and outlook of this work is given in section 4.
2. Methods and materials
2.1. Monte Carlo simulations
The simulation of positron emitter production in carbon ion therapy requires accurate models of nuclear 
interactions and their cross sections, as well as an accurate description of secondary fragment fluences. Since 
empirical data about these values are limited, MC simulations struggle to precisely predict secondary particle 
production in arbitrary cases (Böhlen et al 2010). For the development of PET predictions via convolution, MC 
simulations from Geant4 version 10.02.p02 are used in this work (Agostinelli et al 2003), under the assumption 
that they describe measured PET distributions within acceptable ranges of uncertainty (Böhlen et al 2010). For 
the modelling of physical processes, the physics list QGSP_BIC_HP (quark-gluon string precompound, binary 
light ion cascade, high precision neutron package (NeutronHP)) is chosen.
In the simulation, a monoenergetic carbon ion pencil beam impinges on a rectangular phantom of solid 
material, and positron emissions and deposited energy are scored in the phantom in slices in depth (bin-
ning  =  0.5 mm). Since 11C and 15O are the most relevant positron emitters in carbon ion therapy (Enghardt et al 
1999, Parodi et al 2002), only these two positron emitter isotopes are considered and tracked. Other positron 
emitters such as 10C also play a role in the PET signal, but they were not considered for this study due to their 
lower production yields and shorter half-lives. Nevertheless, the methods presented herein can be easily extended 
to those cases. PMMA, water, PE, bone and a reference material serve as phantom materials. The so-called refer-
ence material is created for the sole purpose of this work and includes all human tissue elements leading to sig-
nificant production of positron emitters. It is used as reference space in which filters are created and convolution 
is performed (section 2.2.2), where other materials could lack some of the considered elements. Properties of 
the phantom materials are displayed in table 1. Biological washout, detector responses and the time course of a 
potential measurement are not considered in this work.
2.2. The convolution approach for PET verification in ion therapy
2.2.1. The convolution framework in proton therapy
Parodi and Bortfeld (2006) suggested a framework in proton therapy to predict the positron emitter activity P(z) 
along depth z in tissue via a convolution of the depth dose distribution D(z) with a filter kernel f (z),
P(z) = D(z) ∗ f (z) =
∫ ∞
−∞
D(z′) f (z − z′)dz′ (1)
Herein, the filter kernel f (z) is obtained analytically via deconvolution, using so-called Q˜ν  functions that 
allow for a closed-form solution of the deconvolution problem in (1). Therefore, the dose distribution and posi-
tron emitter activity distribution along depth are fitted with a linear combination (one, and one to three terms, 
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respectively) of these Q˜ν  functions, which are built from a convolution of a Gaussian and a powerlaw function 
(Bortfeld 1997).
The filter parameters are refined via minimization of differences between the convolution of the filter kernel 
with dose distributions at different energies and MC simulated PED.
For each interaction channel of the primary ion with a target nucleus resulting in a positron emitter, one fil-
ter is created in the reference space. This framework is generalized to inhomogeneous media with a path length 
operator F  that converts—analogously to the water equivalent path length formalism used for treatment plan-
ning—the depth z in a specific medium into depth z∗ in a reference space via
F : z → z∗ =
∫ z
0
ρel(z′)
ρel,ref
dz′, (2)
where ρel(z′)/ρel,ref  is the electron density at depth z′ in the medium of interest relative to the one in the 
reference material, and the integration is performed over z′ along the depth in real space from the phantom 
entrance at depth z′ = 0 mm to the depth z of interest (Parodi and Bortfeld 2006). After transformation of 
the depth dose distribution in real space via the path length operator F  into the reference space of ’reference’ 
material (properties and composition see table 1), the convolution of the dose distribution with filter kernels 
is applied in the homogeneous reference space. Resulting distributions are transformed back to real space with 
inhomogeneous target materials using the inverse operator F−1.
Since the nuclear density of the target nuclei and the tissue characteristics influence the strength of the PET 
signal, the convolved positron emitter distributions are multiplied with weighting factors according to the tissue 
composition at each depth. This local factor gi(z) is defined via
gi(z) =
[
wi(z)ρ(z)
wi,refρref
] [
ρ(z)ρel,ref
ρel(z)ρref
]
, (3)
where wi(z)/wi,ref  is the fraction by weight of the target nucleus involved in the reaction channel at depth z of 
the target material relative to the one in the reference material, and ρ(z)/ρref  and ρel(z)/ρel,ref  are the mass and 
electron density of the target medium at depth z relative to the one of the reference space, respectively. Finally, the 
total positron emitter distribution is calculated via
P(z) =
N∑
i=1
gi(z) F−1 [F(D(z)) ∗ fi(z)] , (4)
where i sums over the contribution of N different positron emitters.
2.2.2. The application of the convolution framework to carbon ion therapy
In carbon ion therapy, positron emitter activity distributions show significant differences to the ones from proton 
therapy, since positron emitters do not only originate in the target nuclei from the tissue but also in the projectile 
particles themselves. 11C for example can be produced as a fragment of the projectile 12C as well as a fragment of a 
target nucleus, e.g. 12C, 14N, or 16O. Consequently, the following main differences in the procedure of convolution 
in carbon ion therapy can be observed when comparing to the one of protons.
 (i)  Four Q˜ν  functions are required to create a filter able to describe the positron emitter activity 
distribution reasonably well, which leads to a more challenging fitting procedure due to the larger 
parameter space.
Table 1. Material properties of the simulated phantoms such as mass and electron densities and mass abundances of the different atoms in 
the target material.
Material Reference PMMA Bone Water PE
Mass density (g cm−3) 1.54 1.19 1.85 1.00 0.94
Electron density (1020 cm−3) 4.71 3.87 5.91 3.34 3.23
Mass abundances
      Hydrogen (H) 2% 8% 6% 11% 14%
      Carbon (C) 31% 60% 28% — 86%
      Nitrogen (N) 26% — 3% — —
      Oxygen (O) 38% 32% 41% 89% —
      Phosphorus (P) 1% — 7% — —
      Calcium (Ca) 3% — 15% — —
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 (ii)  The calculated filter is strongly energy-dependent and does not reproduce the positron emitter 
activity distribution (especially the peak height and width) when it is applied to other energies. This is 
illustrated in figure 1 where the filter developed for carbon ions impinging on the reference material 
with an energy of 200 MeV n−1 is applied to the distributions of the same carbon ion beam at different 
energies. Additionally to the peak, the build-up and tail are not reproduced well either, in contrast to 
the distal-fall off position which is predicted with deviations below 1 mm.
Due to the strong influences of the target material and ion energy on the PED, the successful application of the 
procedure with one filter for each positron emitter is not possible. In this work, we have developed a procedure 
that accounts for the different properties of positron emitter production in carbon ion therapy, i.e. the projectile 
and target fragmentation, the energy dependence, as well as the material dependence. Separation of the projectile 
contribution (positron emitters 11C as fragments from the projectile 12C) and the target contribution (positron 
emitters 11C and 15O as fragments from nuclei in the target medium) allows the prediction of positron emitter 
activity distributions in homogeneous phantoms. With various filters and the convolution method, the distal 
fall-off position of the positron emitter activity distribution is predicted, while the rest of the positron emitter 
activity distribution is fully characterized by the properties of the target medium, the energy of the incoming 
carbon ion, and empirically obtained analytical functions.
Separation of the target and projectile contributions
After a nuclear reaction resulting in a positron emitter, it is not possible to extract information in Geant4 whether 
the created positron emitter originated in the projectile or target nucleus. However, energy and momentum 
conservation considerations allow for a reasonable prediction. In particular, carbon ions of therapeutical 
energies only transfer a small amount of kinetic energy to the target nucleus at rest in the tissue in peripheral 
nucleus-nucleus interactions (Pshenichnov et al 2006). This process leads to the typical positron emitter activity 
distribution in carbon ion therapy: a broad build-up and tail from positron emitters created mainly from target 
nuclei that stay at their site of production, and an activity peak close to the Bragg peak position where the positron 
emitters formed from the projectile particle come to rest.
A plot of the kinetic energies of fragment particles 11C after nuclear interactions of projectile particles 12C 
with target nuclei in MC simulations are plotted against the kinetic energy of the projectile at the time of interac-
tion in figure 2 (red dots) and reveals two groups of 11C fragments. One group has a low kinetic energy (below 
0.2 GeV) which is independent of the kinetic energy of the projectile in the interaction. The kinetic energy of the 
other group is higher and rises with the projectile energy. Based on the aforementioned considerations, it is rea-
sonable to assume that the first group of low kinetic energy originates in target atoms at rest when they are hit by 
the projectile particle, while the high energy group corresponds to fragments of the projectile itself.
To separate the two groups, a 70% threshold of the incident kinetic energy of the particle is selected (shown in 
the figure in blue). Positron emitters with an energy above this threshold are considered to originate in the pro-
jectile particle (11Cproj), while the ones with an energy below the threshold are considered to originate in target 
atoms (11Ctarget). Since the two groups are well separated, any other energy threshold value between 50% and 90% 
leads to a very similar result. Small deviations occur only in the low energy region but do not have a significant 
impact on the final result, since only relatively few particles occur in this region.
Figure 1. 11C distributions from interactions of the primary 12C with carbon nuclei targets. A filter developed for 200 MeV n−1 
carbon ions impinging on the reference material is applied to depth dose distributions at different carbon ion energies (100 MeV 
n−1, 200 MeV n−1, 300 MeV n−1, and 400 MeV n−1). The resulting convolved 11C distributions (red) do not match the corresponding 
MC simulated 11C distributions (blue) at 100 MeV n−1, 300 MeV n−1, and 400 MeV n−1.
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The projectile contribution
The projectile contribution 11Cproj to the positron emitter profile is an order of magnitude larger than the one in 
the build-up and tail region and allows to determine the range of the positron emitters formed from the projectile 
particles. Therefore, it provides information correlated with the range of the incident ions in the medium, the 
most important quantity of interest in treatment verification tasks (Maccabee et al 1969, Kraan 2015).
To predict the distal fall-off position of the positron emitter distribution, the convolution procedure is used. 
Therefore, positron emitter distributions and depth dose distributions from MC simulations are fitted with 
Q˜ν(z) functions as it has been described in the previous section, and filters are created analytically for each posi-
tron emitter and each target nucleus. The filtering approach is solely used to predict the distal fall-off position 
and complemented by other methods used to estimate the shape of the PED distribution.
With the distal fall-off position fixed, the next step is to estimate the PED peak width. This is accomplished 
calculating the range Rf  of 11C isotopes in the target material, fixing the beginning of the positron emitter peak. 
To calculate the range Rf , the concept of residual range is used. The residual range rf(Ez∗) of the 
11C isotope 
depends on the residual energy Ez∗ at the depth of interaction z* and can be estimated from the residual range 
rp(Ez∗) of the projectile particle at this depth and the mass and charge numbers of projectile and fragment Ap,f  
and Zp,f, respectively, via (Schardt et al 2010):
rf(Ez∗) =
Z2p
Z2f
Af
Ap
rp(Ez∗) (5)
For 11C isotopes in 12C therapy, this formula reduces to r11C(Ez∗) =
11
12 r12C(Ez∗). The depth Rf  at which a posi-
tron emitting fragment comes to rest can be estimated via a sum of the depth of interaction and the remaining 
range of the fragment particle, i.e.
Rf(z
∗) = z∗ + rf(Ez∗) = z∗ +
11
12
rp(Ez∗) = z
∗ +
11
12
[rp(E0)− z∗] (6)
where rp(E0) denotes the residual range of the projectile at the beginning of its path with initial energy E0. To 
verify this linear relationship, the MC simulated number of 11C particles created at different depths is plotted 
against their depth of positron emission in figure 3 and displays a good match between the calculated range and 
MC simulated ones which are smeared by a Landau distribution corresponding to the Landau distribution of the 
energy loss of the particles (Wilkinson 1996).
As a consequence, it is possible to determine the number of positron emissions at each depth in the peak 
region of the 11Cproj profile based on a linear mapping of the material properties of their production sites along 
the path of the beam. The proximal margin of the positron emitter peak is determined by the 
Z2p
Z2f
Af
Ap
= 1112 = 92% 
of the incident particle range, which in turn is determined by the 80% distal fall-off position of the MC simulated 
depth dose distribution. The proximal and distal limits of the 11Cproj peak define a mapping window in which the 
Figure 2. Kinetic energy Ekin,frag  of 
11C fragments after the interaction of the projectile 12C of energy Ekin,proj with a nucleus in the 
target material. Two different groups can be observed, separated by a 70% threshold line (blue). All fragments situated in the plot 
below the threshold line are considered to be target fragments. In contrast, all fragments above the line are considered to originate in 
the projectile particle. Data are obtained in Geant4.
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materials crossed during the ion path will be mapped into. For example, the distal limit of the mapping window 
for 300 MeV n−1 12C ions in the reference material with a range of 12.3 cm is determined via the convolution 
method to be 12.3 cm. The shortest range of 11Cproj, and therefore the proximal limit of the mapping window, is 
for 11Cproj created when the nuclear interaction leading to their production occurs at the very beginning of the 
phantom (i.e. z*  =  0 in (6)) and is therefore at a depth of 1112 · 12.3 cm  =  11.3 cm. The linear mapping of the total 
range to this window decreases the binning to a factor of 12.3 cm−11.3 cm12.3 cm = 0.08. Since the binning in depth for the 
phantoms used herein was 0.5 mm, the contribution of each one of those bins to the 11Cproj peak will be squeezed 
into 0.04 mm.
With the limits of the mapping window determined, the aforementioned contribution must be calculated. 
This takes the form of three separate factors based on the materials along the path of the ions and their energy. 
The first factor is the g-factor, gi(z) (see (3)), the second is the fluence loss of 12C, and the third is an energy-
dependent scaling factor to account for the height of the positron emitter peak at different depths based on the 
fluence loss of the 11Cproj.
Regarding the fluence loss correction for 12C, it shows an exponentially decreasing behaviour in depth:
Φ12C(z) = Φ0 exp(−Nσz), (7)
where Φ0 is the fluence at the entrance of the phantom, N is the density of atomic nuclei in the tissue and σ is the 
reaction cross section. This behaviour can be approximated by a linear function of negative slope along the depth 
in tissue,
Φ12C(R, z) =
m(R− z) + 1
mR+ 1
= 1− m
mR+ 1
z (8)
where R is the particle range and m is a material dependent factor (Lee et al 1993).
On the other hand, the fluence loss of the 11C along the depth in tissue was assessed with MC simulations and 
it was found to have a cubic dependency on the energy
hi(E) = hi,1E
3 + hi,2E
2 + hi,3E + hi,4 (9)
and is characterised by four coefficients hi,1−4 for each target nucleus i. This correction makes the positron emitter 
activity peak decrease in depth.
Finally, to account for energy loss fluctuations, a Gaussian G(z) of empirically determined width σG = 1.2 
mm in the reference material is used.
Combining all corrections, the distribution of the predicted positron emitter profile of the projectile part 
11Cproj that is to be mapped into the peak region defined above is given by
PEDi,proj(E, z) = hi(E) {[gi(z) · Φ12C(z)] ∗ G(z)} . (10)
An example of the projectile distributions predicted with this approach in comparison to the ones from MC 
simulations is shown in figure 4 for the interaction of the projectiles with carbon (figure 4(a)) and oxygen (figure 
4(b)) targets.
Figure 3. Depth of interaction versus depth of positron emission of 11Cproj after carbon ion irradiation at 300 MeV n−1 of a 
phantom of reference material. Additionally, the estimated range of the 11C projectile particles from (6) is indicated with a red 
dashed line, and the MC simulated 11C projectile distribution is shown in solid green.
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The target contribution
The contribution 11Ctarget to the positron emitter distribution originating in the target nuclei has a characteristic 
behaviour, as it is shown in figures 4(c)–(e), and is described best by analytical functions. In the part of the 
positron emitter distribution before the Bragg peak of the depth dose distribution, positron emitters are created 
in interactions from the projectile with the target nuclei. With increasing depth interactions of secondary 
particles with the target nuclei in the tissue also contribute to the number of positron emitters, leading to the 
build-up-like behaviour which is independent of the energy of the projectile. Therefore, this build-up part of the 
distribution is described for each positron emitter species i separately by the analytical function
Pi,b(z) = Pi,b,max[1− αi exp(−ciz)] (11)
that approaches the theoretical maximum number Pi,b,max of produced positron emitters in tissue at large 
depths, where αi is determined by the number of positron emitters at the entrance of the phantom, and ci is a 
factor considering the build-up rate. For each target nucleus i and positron emitter species, this function is fitted 
to simulated data and characterized by the three different coefficients. It is evaluated from the beginning of the 
phantom until the maximum position of the convolved positron emitter distribution from the previous section, 
which is not equal to the maximum of the predicted projectile PED (compare figures 1 and 4(a) and (b)).
In the distal part of the distribution beyond the peak, the model does not describe the simulation results any-
more, since the production of secondary particles declines. In this case, a hyperbola function was found to yield a 
good agreement to simulated results and is correlated with the energy E via
Figure 4. PED from the interaction of a 12C ion beam of energies of 100 MeV n−1, 200 MeV n−1, 300 MeV n−1, and 400 MeV n−1 
with the different components considered: projectile contribution of 11C from carbon (a) and oxygen (b) as target nuclei; target 
contribution of 11C from carbon (c) and oxygen (d) as target nuclei; target contribution of 15O from oxygen (e) as target nucleus. 
Monte Carlo simulated positron emitter and dose profiles are shown in solid blue and green dashed, respectively. The prediction 
from the analytical approach is shown in red solid. Note the different scales of the PEDs.
Phys. Med. Biol. 64 (2019) 105022 (13pp)
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Pi,t(z) = βiE
3 1
z
, (12)
where βi is a scaling parameter. The gap between the end of the build-up function (maximum position of 
convolved PED) and beginning of tail (10% distal fall-off position of the convolved PED) is interpolated linearly.
An example of these target positron emitter profiles for projectile energies between 100 MeV n−1 and 
400 MeV n−1 is shown in figures 4(c)–(e).
Combination of projectile and target contributions
To obtain the prediction of the total positron emitter distribution, the previously presented approaches are 
combined. For each element present in the target material that leads to significant production of positron 
emitters (here: hydrogen, carbon, nitrogen, oxygen, phosphorus, and calcium), a filter is created to determine 
the distal fall-off position of the predicted positron emitter distribution, the local factors gi(z) of the material are 
calculated and mapped to the depth of possible ranges of the 11C and the aforementioned corrections are applied 
to find the projectile contribution of 11C of each element. Subsequently, the target contribution is calculated for 
each element and positron emitter (here: 11C and 15O) using the analytical functions introduced in the previous 
paragraphs.
Validation
To show the feasibility of this approach, it is first applied to distributions in the case of monoenergetic irradiation 
of the homogeneous reference material (introduced in section 2.1 and table 1). Since SOBPs are clinically more 
relevant than monoenergetic irradiation, a SOBP is imitated by overlaying 25 monoenergetic carbon ion beams 
of small energetic difference (∆E = 2 MeV n−1) in the homogeneous reference material and in a slab phantom 
consisting of four layers of different materials: water (10 cm), bone (2 cm), polymethyl metacrylate (PMMA, 
10 cm), and reference material (10 cm). Slab phantoms give the possibility to directly obtain laterally integrated 
distributions and the plots depicted in the figures shown are normalized to the volume of each slab. All analytically 
predicted positron emitter distributions PEDconv(z) are compared to MC simulated ones PEDMC(z) and 
evaluated via the mean relative error (MRE) to the maximum of the MC simulated positron emitter distribution
MRE[PEDconv(z), PEDMC(z)] =
1
N
∑N
i=1 |PEDconv(zi)− PEDMC(zi)|
maxi[PEDMC(zi)]
 (13)
for depths between z  =  0 mm and z  =  300 mm.
3. Results
3.1. Monoenergetic irradiation of homogeneous phantoms
The 11C (projectile and target contribution) and 15O (target contribution) distributions of monoenergetic 
carbon ion beam irradiation at 100 MeV n−1, 200 MeV n−1, 300 MeV n−1 and 400 MeV n−1 of a homogeneous 
phantom are predicted analytically within less than a second and shown in figure 5 (red solid).
For comparison, MC simulated, laterally integrated distributions of dose and positron emitters are shown in 
dashed green and solid blue, respectively. The predicted distributions match the simulation results for all ener-
gies. The MRE from the analytical description and MC simulation to the maximum of each MC simulated dis-
tribution is below 1% for the 11C projectile contribution and below 3% for the 11C and 15O target contributions 
for all energies. The distal fall-off positions are predicted with a maximum deviation of 0.6 mm. A quantitative 
evaluation for each energy is shown in table 2.
Discrepancies for the target component are observed, especially for lower energies. This was expected since 
the parameterization of the build-up part was based on the parameter Pi,b,max, which is the theoretical maximum 
number of positron emitters at large penetration depths. This approach ensures that the parameterization is 
applicable to any energy, with the consequence of an impact on accuracy for lower energies.
3.2. Spread out Bragg peak in homogeneous and heterogeneous phantoms
The predicted total 11C distributions from the analytic approach in comparison to the ones from MC simulations 
are displayed in figure 6 for a spread out Bragg peak (242 MeV n−1–290 MeV n−1 and 230 MeV n−1–280 MeV 
n−1) in the reference material and a slab phantom, respectively. In the homogeneous reference material (plot 
(a)), the analytically predicted distribution match the MC simulated results well. Small deviations occur in the 
height of the positron emitter peak, giving rise to a MRE of 1.2% for the total 11C distribution. When applying 
this procedure to the SOBP in the inhomogeneous slab phantom (plot (b)), the build-up and tail of analytically 
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predicted and MC simulated distributions match again very well, while the height of the peak is underestimated 
with the analytical approach. The MRE amounts to 1.8% in this case. Such an underestimation is attributed to 
the small deviations that exist for each single energy distribution that pile-up when combined to form a SOBP.
Figure 6 depicts also the 15O distributions obtained from the target oxygen, which is the origin of most of the 
15O contribution. A systematic good agreement is obtained for the homogeneous reference material phantom 
(plot (c)) and slab phantom (plot (d)). Larger deviations are observed in plot (d) around the transition from 
water (medium I) to bone (medium II), which can be explained by the end of the range of some of the beams at 
or shortly after the transition. The prediction in water (medium I) is consistently lower than the MC simulations 
in the case of slab phantom (plot (d)), while such discrepancy is not observed in the case of the reference homo-
geneous phantom (plot (c)). This is attributed to the lower percentage of oxygen in the reference material with 
respect to water (38% versus 89%, see table 1), which makes any inaccuracy in the parameterization of the target 
contribution more noticeable.
The last row of figure 6 shows the sum of the first two rows, with similar trends to the 11C distribution of the 
first row due to its major contribution to the PED.
It should be noted that the shape of the SOBP is not flat to account for realistic slope when delivering a 
biological flat SOBP.
Figure 5. PED of the 11C contribution projectile (a) and target (b), as well as the 15O distribution (c) and the total distribution 
(sum of the first three distributions, (d)) after monoenergetic 12C ion irradiation of the reference material with energies of 100 MeV 
n−1, 200 MeV n−1, 300 MeV n−1, and 400 MeV n−1. Monte Carlo simulated positron emitter profiles are shown in solid blue, while 
the prediction from the analytical approach is shown in solid red. In the top left image, the MC simulated dose distributions are 
overlayed (green dashed). Note the different scales of the PED.
Table 2. Mean relative errors (MRE) to the maximum of the MC-simulated positron emitter profiles for irradiation of homogeneous 
reference material with monoenergetic 12C beams of 100 MeV n−1, 200 MeV n−1, 300 MeV n−1 and 400 MeV n−1. The results are displayed 
separately for the 11C projectile (11Cproj) and target (11Ctarget) contribution, the 15O target (15Otarget) contribution, and the sum of these 
distributions (11C  +  15O). Additionally, the absolute difference ∆PED80% in depth of the 80% distal fall-off positions of the total positron 
emitter distributions (11C  +  15O) is indicated in the last column.
Energy of primaries  
(MeV n−1)
MRE
∆PED80% 
11C  +  15O (mm)11Cproj (%) 11Ctarget (%) 15Otarget (%) 11C  +  15O (%)
100 0.3 2.0 1.7 0.6 0.6
200 0.4 2.8 2.5 0.8 0.4
300 0.2 2.2 2.2 0.8 0.3
400 0.4 1.6 1.9 0.8 0.0
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4. Discussion and conclusion
In this work, the feasibility of an analytical approach to predict positron emitter distributions from depth dose 
distributions in carbon ion therapy was shown. Due to the strong dependence of the positron emitter distribution 
on the target properties and the incident carbon ion beam energy, it was not feasible to apply the filtering 
approach in the same way as in the case of proton therapy. Instead, the convolution approach was used to predict 
only the position of the positron emitter peak and its distal fall-off, while the positron emitter distribution itself 
is described with analytical functions. Therefore, a distinction is made between the contributions coming from 
different target nuclei involved in the nuclear reaction resulting in the positron emitters, the different positron 
emitters themselves (here 11C and 15O), as well as their origin, i.e. if the positron emitter is a projectile fragment 
or a target one. The positron emitter peak is generated by the projectile contribution of 11C created in nuclear 
reactions with different target nuclei and is limited in depth. While its beginning is fixed to 1112 of the projectile 
12C range, its distal fall-off position is determined via the 10% distal fall-off position of the convolved positron 
emitter distribution from the filtering approach. Local g-factors quantify the positron emitter distribution within 
the peak, considering the electron and mass density of the so far traversed medium, the fluence loss of the carbon 
ions and isotopes in the medium, and a Landau distribution blurring the edges. In contrast, the contributions 
from positron emitters originating in target nuclei shape mainly the build-up and tail region of the positron 
emitter distribution. While the build-up from the beginning of the phantom to the positron emitter peak is 
characterised by a sum of asymptotically growing exponential functions for each positron emitter and each target 
Figure 6. 12C ions with energies between 230 MeV n−1 and 280 MeV n−1 impinge on the homogeneous reference material (left 
column) and 12C ions with energies between 242 MeV n−1 and 290 MeV n−1 impinge on a slab phantom (right column) where 
different materials are indicated with different gray values in background (I: water, II: bone, III: PMMA, IV: reference material).  
(a) and (b) show 11C profiles from the interaction of the 12C projectile with all present target nuclei; (c) and (d) show the 15O profiles 
from target oxygen; (e) and (f) show the sum of the first two rows. Monte Carlo simulated PED and dose profiles are shown in solid 
blue and dashed green, respectively. The prediction from the analytical approach is shown in solid red.
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nucleus, the tail beyond the peak is estimated—again for each positron emitter and each target nucleus—with a 
hyperbolic function that includes a cubic dependency on the energy of the primary particles.
With this approach, positron emitter distributions in homogeneous and heterogeneous phantoms have been 
predicted with satisfactory agreement to MC simulated results. Mean relative errors to the maximum of the dis-
tributions were below 4% in all tested cases, and distal fall-off positions matched well with maximum deviations 
of 0.6 mm for homogeneous and 1.3 mm for inhomogeneous phantoms. While total distributions of monoener-
getic irradiation of homogeneous phantoms are predicted with very high precision and only small deviations in 
the build-up region, also SOBPs are predicted with good agreement to MC simulated results in homogeneous as 
well as inhomogeneous phantoms. Acceptable deviations occur only in the absolute height of the positron emit-
ter peak, while the shape is described well, also in proximity of slab interfaces.
Although the results shown in this work are satisfying, they still need to be taken under careful consideration 
of uncertainties in the systematic principle. Since all analytically predicted positron emitter distributions have 
been based on MC simulations, their benefit comes only into effect, if MC simulated distributions accurately 
and reliably describe measured distributions. However, different physics models in Geant4 already predict devia-
tions in the positron emitter production and can deviate from measurements. Therefore, the analytical method 
is limited by the simulation accuracy of the MC simulation platform. Other groups work on the improvement of 
the reliability of MC predicted PET distributions which will make this method more feasible to real applications. 
Additionally, a method similar to the one from Bauer et al (2013b) is conceivable to refine the PET predictions to 
clinic-specific conditions.
The work of Priegnitz et al (2012) proposed an interesting approach. Although a thorough comparison 
between the aforementioned study and the one herein is very difficult due to the different goals and metrics 
involved, some discussion can be done. Herein, mean relative errors were below 4%, while in Priegnitz et al the 
normalized root mean square error (NRMSE) showed errors below 20%, when comparing predicted and meas-
ured distributions. The two metrics cannot be directly compared since the squaring of the residuals in the case 
of NRMSE will give more weight to larger deviations. Nevertheless, comparing the different plots herein and 
in Priegnitz et al (2012), the level of agreement in signal amplitude is similar. However, the striking differences 
between the two approaches are the simplicity and the work needed for its development. Priegnitz et al explic-
itly state that they want to avoid the filtering approach of Parodi and Bortfeld (2006) since it relies on cross 
section data with the use of Monte Carlo tools. However, their method relies on experimental yield data that, 
although easier to obtain than experimental cross section data, requires an extensive experimental campaign, and 
is impacted by the detector response and unavoidable uncertainties in separating the different isotope contrib-
utions with decay fitting of measured activity. If the yield data are obtained with Monte Carlo tools, inaccurate 
cross sections may have to be used, which (Priegnitz et al 2012) meant to avoid. However, their approach needs a 
considerable amount of tabulated data, which also resembles the work of Sterpin et al for prompt-gamma pre-
diction in proton therapy (Sterpin et al 2015). In the present study, some parameterizations are done and several 
approximations are used, namely for the estimation of the signal amplitude of the distributions (build-up, peak 
height and width, and tail), hence introducing some complexity. Despite this disadvantage, the present work 
shows maximum range deviations up to 1.3 mm and, for this estimation alone, only six filter functions (i.e. to 
predict the 11C distributions for the six target nuclei considered) and the dose distribution are required to predict 
the distal fall-off position. Finally, the method presented herein uses MC-based data but, if better cross sections, 
or other type of experimental or MC-based data are available, it can be further improved using such new inputs 
without much effort or time. Once the baseline filters and parameterizations are obtained, further improvements 
can be done with fine tuning of the filter functions parameters or the parameters of the parameterizations, thus 
making future developments considerably more practical than the approach of Priegnitz et al (2012), which is 
impacted by the amount of experimental data required and granularity of the methods employed.
More recently, the work of Pennazio et al (2018) shows the use of an innovative Monte Carlo tool to predict 
PET images in carbon ion therapy monitoring, and the comparison of its outcomes with measured PET data. A 
direct comparison with the results herein is difficult since different metrics were used and the study in Pennazio 
et al is with patients, which is more challenging. Nevertheless, based on the results shown, it is safe to consider that 
the tool proposed by Pennazio et al is more accurate in terms of both yields and prediction of distal fall-off posi-
tions than the one we propose herein. However, our solution offers some advantages. First, the computing time. 
In Pennazio et al (2018) the computing time required is not mentioned and, even if it performs faster than full-
blown Monte Carlo packages, one can assume that the analytical method proposed here is considerably faster, 
providing results within a few seconds. Additionally, the solution herein has the potential to be further improved 
in terms of accuracy and extended, for example, for inclusion in a treatment planning system (TPS), as it was 
already demonstrated for the proton case using the filtering approach (e.g. Frey et al (2014)). Such an implemen-
tation in a TPS also allows for a relatively straightforward translation of the prediction tool to any therapy centre 
since it makes it depending solely on the built-in beam model. In the case of Pennazio et al, the approach requires 
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an accurate description of the beamline in the simulation setup, as well as several calibrations and validations 
(Pennazio et al 2018).
The demonstrated results show the possibility of predicting PET profiles within a few seconds in different 
materials, which arises promising prospects for potential future applications in more complex cases. In the next 
steps, this method will need to be fully extended to three dimensions to be able to consider also the spatial distri-
bution of positron emitters in three dimensions of an incoming ion beam of finite size, as well as extensive tests 
with patient CT data. Additionally, the results of the current filtering method and its parameters will need to be 
evaluated and potentially refined with measured data. In potential applications to living tissues, biological wash-
out will blur the signal and will need to be taken into consideration (Toramatsu et al 2018), as well as the time-
course of irradiation and the decay of the positron emitters over time (Parodi et al 2007a). Finally, this method 
has the potential to replace computationally-intensive MC simulations to predict the PET images in a PET moni-
toring workflow. This can be achieved by applying the irradiation delivery timing parameters to obtain activity, 
and then couple the activity maps with either analytical methods to model the PET scanner response or simulate 
the transport of the 511 keV photons to the scanner. Regarding the aforementioned scanner response models, a 
possibility is to approximate the scanner response by convolving the production data with a three-dimensional 
Gaussian kernel, which is especially suitable to full-ring PET scanners (e.g. Parodi et al (2007b), Attanasi et al 
(2011) and Bauer et al (2013a)). In the case of explicit simulations of the photons, the time-consuming model-
ling of ion transport is circumvented, while the photon transport can be done very quickly. A realistic number of 
photons to be transported in the context of this work require seconds or a few minutes, while ions require hours 
or even days, depending on the uncertainty level. The method presented herein can also contribute to clinical 
decisions regarding treatment plan parameters that may allow for better PET monitoring, or be used as input to 
other methods, such as reconstructing dose distributions based on PET monitoring (e.g. Hofmann et al (2019)).
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